Fc Sialylation Prolongs Serum Half-Life of Therapeutic Antibodies

  • Bas M
  • Terrier A
  • Jacque E
  • et al.
N/ACitations
Citations of this article
135Readers
Mendeley users who have this article in their library.

Abstract

The long serum t1/2 of IgGs is ensured by their interaction with the neonatal Fc receptor (FcRn), which salvages IgG from intracellular degradation. Fc glycosylation is thought not to influence FcRn binding and IgG longevity in vivo. In this article, we demonstrate that hypersialylation of asparagine 297 (N297) enhances IgG serum persistence. This polarized glycosylation is achieved using a novel Fc mutation, a glutamate residue deletion at position 294 (Del) that endows IgGs with an up to 9-fold increase in serum lifespan. The strongest impact was observed when the Del was combined with Fc mutations improving FcRn binding (Del-FcRn+). Enzymatic desialylation of a Del-FcRn+ mutant or its production in a cell line unable to hypersialylate reduced the in vivo serum t1/2 of the desialylated mutants to that of native FcRn+ mutants. Consequently, our study proves that sialylation of the N297 sugar moiety has a direct impact on human IgG serum persistence.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Bas, M., Terrier, A., Jacque, E., Dehenne, A., Pochet-Béghin, V., Beghin, C., … Monnet, C. (2019). Fc Sialylation Prolongs Serum Half-Life of Therapeutic Antibodies. The Journal of Immunology, 202(5), 1582–1594. https://doi.org/10.4049/jimmunol.1800896

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 46

62%

Researcher 24

32%

Professor / Associate Prof. 4

5%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 36

55%

Immunology and Microbiology 13

20%

Agricultural and Biological Sciences 10

15%

Chemical Engineering 6

9%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free